Versant Capital Management Inc Boosts Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Versant Capital Management Inc boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 274.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 457 shares of the company’s stock after acquiring an additional 335 shares during the quarter. Versant Capital Management Inc’s holdings in Henry Schein were worth $32,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the company. Cromwell Holdings LLC boosted its position in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares during the period. Farther Finance Advisors LLC raised its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after acquiring an additional 346 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in Henry Schein by 282.1% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company’s stock valued at $109,000 after purchasing an additional 1,100 shares during the period. Wilmington Savings Fund Society FSB acquired a new position in Henry Schein during the 3rd quarter worth $109,000. Finally, Huntington National Bank increased its holdings in Henry Schein by 16.8% during the 3rd quarter. Huntington National Bank now owns 1,515 shares of the company’s stock worth $110,000 after purchasing an additional 218 shares during the period. 96.62% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Henry Schein

In other Henry Schein news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction that occurred on Monday, November 18th. The stock was sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.14% of the stock is currently owned by insiders.

Henry Schein Price Performance

HSIC stock opened at $71.67 on Wednesday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The company has a market capitalization of $8.94 billion, a P/E ratio of 29.49, a PEG ratio of 2.30 and a beta of 0.89. The business has a 50 day simple moving average of $72.13 and a 200-day simple moving average of $70.37. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.32 EPS. As a group, equities analysts anticipate that Henry Schein, Inc. will post 4.78 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have recently commented on HSIC shares. Barrington Research reissued an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Wednesday, November 6th. Mizuho assumed coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price objective on the stock. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their price objective for the stock from $69.00 to $84.00 in a research report on Monday. Evercore ISI raised their price target on Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Seven equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $79.40.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.